Current Oncology Reports

Article	Citations
Changing the Perspective on Fertility Preservation for Women with Metastatic or Advanced Stage Cancer	181
Advances in Targeted Therapy for Neurofibromatosis Type 2 (NF2)-Associated Vestibular Schwannomas	119
New Developments in VHL-Associated Neuroendocrine Neoplasms	118
NRG1 Fusions: The New Kid on the Block	90
Immunotherapeutic and Targeted Strategies for Managing Brain Metastases from Common Cancer Origins: A State-of-the-Art Review	62
Immunotherapy in Biliary Tract Cancers: Where Are We?	60
Cardiotoxic Effects Following CAR-T Cell Therapy: A Literature Review	56
Opportunities and Challenges for a Histology-Agnostic Utilization of Trastuzumab Deruxtecan	55
The Difficult Airway in Patients with Cancer	54
The Microbiome in Advanced Melanoma: Where Are We Now?	52
Head and Neck Mucosal Melanoma: Where Are We Now?	48
Current Trends and Challenges of Microbiome Research in Prostate Cancer	44
AXL Inhibitors: Status of Clinical Development	42
An Integrated Care Approach to Improve Well-Being in Breast Cancer Patients	41
An Overview of Angiogenesis in Bladder Cancer	40
Cellular Therapy in NSCLC: Between Myth and Reality	40
Novel Surgical Initiatives in Gastroenteropancreatic Neuroendocrine Tumours	39
Primary or Interval Debulking Surgery in Advanced Ovarian Cancer: a Personalized Decision—a Literature Review	39
Appendiceal Neuroendocrine Neoplasms: an Update for 2023	39
How Have Targeted Agents Changed the Treatment Landscape for Elderly Patients with CLL?	35
Targeting the PI3K Pathway in Gynecologic Malignancies	33
Proton Therapy in The Treatment of Head And Neck Cancers- Review	31
Breast cancer Treatment and Fertility Preservation: A Narrative Review of Impacts, Strategies and Ethical Considerations	30
A Systematic Review and a Meta-analysis of Randomized Controlled Trials’ Control Groups in Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)	30
CAR-T Therapies in Solid Tumors: Opportunities and Challenges	30

Geographical Disparities in Colorectal Cancer in Canada: A Review	28
Development of Effective Siglec-9 Antibodies Against Cancer	28
Surgical Management of the Primary Tumor in Stage IV Small Intestinal Neuroendocrine Tumors: To Operate or Not to Operate, That Is the Question	27
Current Management of Neuroendocrine Tumour Liver Metastases	27
Evolving Role of CAR T Cell Therapy in First- and Second-Line Treatment of Large B Cell Lymphoma	27
Antibody-Drug Conjugates in Breast Cancer: The Road Towards Biologically-Informed Selection and Sequencing	26
Use of Circulating Tumor DNA to Guide Decision-making in Adjuvant Colon Cancer	26
Biomarkers in the Immuno-oncology Interface of Triple Negative Breast Cancer: A Scoping Review with Perioperative Considerations	25
Pre- and Post-Microsurgical Rehabilitation Interventions and Outcomes on Breast Cancer–Related Lymphedema: a Systematic Review	25
Diagnostic Accuracy of Liquid Biopsy for Oral Potentially Malignant Disorders and Head and Neck Cancer: an Overview of Systematic Reviews	25
Vascular Inflammation, Cancer, and Cardiovascular Diseases	25
Role of the Microbiome and Diet for Response to Cancer Checkpoint Immunotherapy: A Narrative Review of Clinical Trials	24
Dedifferentiated Chondrosarcoma: Diagnostic Controversies and Emerging Therapeutic Targets	23
Surgery for Recurrent Epithelial Ovarian Cancer	23
Elderly Rectal Cancer: An Updated Review	23
Inequities Among Cancer Caregivers with Diverse Identities: A Review of the Literature and Future Directions	23
The Evidence for Using Artificial Intelligence to Enhance Prostate Cancer MR Imaging	22
Small Cell and Other Rare Histologic Types of Cervical Cancer	22
Current Diagnostic Tools for Breast Cancer-Related Lymphedema	22
Management of Peripheral T-cell Lymphomas and the Role of Transplant	21
Current Status on Management of Primary Plasma Cell Leukemia	21
Advancements in the Diagnosis, Treatment, and Risk Stratification of Non-Muscle Invasive Bladder Cancer	21
Therapeutic Management in Elderly Male Breast Cancer Patients: A Scoping Review	21
Unveiling the Hidden Links: Periodontal Disease, Fusobacterium Nucleatum, and Cancers	20
Epidemiology of Cancer in Older Adults: A Systematic Review	20
Human Epidermal Growth Factor Receptor 2 Positive Advanced Gastric or Esophagogastric Adenocarcinoma: Reflecting on the Past to Gain a New Insights	20
Integrative Medicine Across the Pediatric Cancer Care Trajectory: A Narrative Review	20
History of Leukemia, Revisited	20
Intratumoral Immunotherapy: Is It Ready for Prime Time?	20
Multimodality Therapies for Localized Prostate Cancer	19
Management of Pathologic Node-Positive Prostate Cancer following Radical Prostatectomy	19
Return to Intended Oncological Therapy: State of the Art and Perspectives	19
Nasal Cavity and Paranasal Sinus Cancer: Diagnosis and Treatment	19
Cardiovascular Effects of Immune Checkpoint Inhibitors: More Than Just Myocarditis	18
Nectin-4: a Tumor Cell Target and Status of Inhibitor Development	18
Integrative Oncology Approaches to Supporting Immune Checkpoint Inhibitor Treatment of Solid Tumours	18
Racial Disparities in Breast Cancer: from Detection to Treatment	18
Cured or Not? Long-term Outcomes of Immunotherapy Responders. Focus on Melanoma	18
Blood–Brain Barrier Disruption for the Treatment of Primary Brain Tumors: Advances in the Past Half-Decade	18
Prevention of Ovarian Cancer: Where are We Now and Where are We Going?	18
Current Approaches to Neoadjuvant Immunotherapy in Resectable Non-small Cell Lung Cancer	18
Limb Amputations in Cancer: Modern Perspectives, Outcomes, and Alternatives	18
Clonal Hematopoiesis of Indeterminate Potential: Current Understanding and Future Directions	18
15 Years Old ALK Gene from Birth to Adolescence; Where to in NBL	18
CDK4/6 inhibitors: The Devil is in the Detail	17
Cardio-Oncology in Childhood: State of the Art	17
Cerebrospinal Fluid Liquid Biopsies in the Evaluation of Adult Gliomas	17
Resectability versus Operability in Early-Stage Non-Small Cell Lung Cancer	17
Oral Health in Patients with History of Head and Neck Cancer: Complexity and Benefits of a Targeted Oral Healthcare Pathway	17
CAR T-cell Therapy for Central Nervous System Lymphoma	17

Options for Rescue Treatment of Patients with AL Amyloidosis Exposed to Upfront Daratumumab	16
Advances in Treatment of Waldenström Macroglobulinemia	16
Correction: Enhanced Recovery in Gynecologic Oncology Surgery—State of the Science	16
Advances in Endocrine Therapy for Hormone Receptor-Positive Advanced Breast Cancer	16
Surviving Burnout as an Oncologist	16
Integrative Geriatric Oncology: A Review of Current Practices	16
Radiogenomics as an Integrated Approach to Glioblastoma Precision Medicine	16
Intracranial Germinomas: Diagnosis, Pathogenesis, Clinical Presentation, and Management	15
Defining The Role for Hormone Therapy in Biochemically Recurrent Prostate Cancer: What Counts as a Win for Patients?	15
Traditional Chinese Medicine Herbs for Breast Cancer Prevention and Survival: A Narrative Review of Epidemiological Studies from Taiwan	15
Tivozanib Monotherapy in the Frontline Setting for Patients with Metastatic Renal Cell Carcinoma and Favorable Prognosis	15
Pelvic Floor Therapy and Initial Interventions for Pelvic Floor Dysfunction in Gynecologic Malignancies	15
New Developments in Image-Guided Percutaneous Irreversible Electroporation of Solid Tumors	15
Direct Oral Anticoagulants for Cancer-Associated Venous Thromboembolism	15
Fertility-Sparing and Less Radical Surgery for Cervical Cancer	15
Use of Antihyperglycemic Drugs and Risk of Cancer in Patients with Diabetes	15
Perioperative Blood Transfusions and Cancer Progression: A Narrative Review	15
Epidemiology of cancer in older adults: a systematic review of age-related differences in solid malignancies treatment	15
Exercise as Medicine in Cardio-Oncology: Reducing Health Disparities in Hispanic and Latina Breast Cancer Survivors	14
Correction to: Postmastectomy Functional Impairments	14
Cold-antibody Autoimmune Hemolytic Anemia: its Association with Neoplastic Disease and Impact on Therapy	14
Adjuvant Therapy in Node-Positive Endometrial Cancer: A Focus on Chemotherapy	14
Optimizing Care: Integrative Oncology in Myeloproliferative Neoplasm	14
Percutaneous Ablation of T1b Renal Cell Carcinoma: An Overview	14
Locoregional Therapy in the Management of Intrahepatic Cholangiocarcinoma: Is There Sufficient Evidence to Guide Current Clinical Practice?	14
Post-acute Care Needs and Benefits of Inpatient Rehabilitation Care for the Oncology Patient	14
An Update in Anticoagulant Therapy for Patients with Cancer-Associated Venous Thromboembolism	13
Current Status of Perioperative Therapy in Muscle-Invasive Bladder Cancer and Future Directions	13
Germline Mutations and Ancestry in Prostate Cancer	13
Enhanced Recovery in Gynecologic Oncology Surgery—State of the Science	13
Clinical Applications and Advancements of Positron Emission Tomography/Computed Tomography in Cardio-Oncology: A Comprehensive Literature Review and Emerging Perspectives	13
The Future Glioblastoma Clinical Trials Landscape: Early Phase 0, Window of Opportunity, and Adaptive Phase I–III Studies	13
Toxicities from BRAF and MEK Inhibitors: Strategies to Maximize Therapeutic Success	13
Hairy Cell Leukemia: Where Are We in 2023?	13
Perceptions, Knowledge, and Attitudes of General Population About Prostate Cancer-Associated Risk Factors: A Systematic Review of Qualitative Studies Focusing on Lifestyle	13
Oral Complications and Management Strategies for Cancer Patients: Principles of Supportive Oncology in Dentistry	13
The Microbiome’s Influence on Head and Neck Cancers	13
Oligometastatic Esophagogastric Cancer: Does It Exist and How Do We Treat It?	13
BCR/ABL-Positive Chronic Myeloid Leukemia in Children: Current Treatment Approach	12
Asparaginase: How to Better Manage Toxicities in Adults	12
Melanoma in Pediatric and Young Adult Patients	12
Evolving Strategies in the Management of Microsatellite Instability-High/Mismatch Repair Deficient Esophagogastric Adenocarcinoma	12
Cell-free Tumor DNA: a Promising Technology for Diagnosis, Surveillance and Therapeutic Decision in Urothelial Carcinoma of the Bladder	12
Integration of Postoperative Radiation Therapy with Cyclin-Dependent Kinase (CDK) Inhibitors	12
ChatGPT in Oncology Diagnosis and Treatment: Applications, Legal and Ethical Challenges	12
Prostate Cancer, Pathophysiology and Recent Developments in Management: A Narrative Review	12
Integrative Oncology Approaches to Reduce Recurrence of Disease and Improve Survival	12
Radiation and Melanoma: Where Are We Now?	12
Advances in Radionuclide Therapies for Patients with Neuro-endocrine Tumors	12
Next-Generation Sequencing—Optimal Sequencing of Therapies in Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)	12
Beneath the Surface: The Emerging Role of Ultra-Processed Foods in Obesity-Related Cancer	12
Beyond Immune Checkpoint Inhibitors: Emerging Targets in Melanoma Therapy	12
Novel Insights of Anti-EGFR Therapy in HNSCC: Combined with Immunotherapy or Not?	12
Genomic Landscape of Pleural Mesothelioma and Therapeutic Aftermaths	12
Effect of Post-diagnosis Physical Activity on Breast Cancer Recurrence: a Systematic Review and Meta-analysis	12
Correction to: Past, Present, and Future Therapeutic Strategies for NF‑1‑Associated Tumors	12
Epigenetic Role of Long Non-coding RNAs in Multiple Myeloma	11
Prostate Cancer in Transgender Women: Epidemiology, Clinical Characteristics, and Management Challenges	11
Liver Cancer Etiology: Old Issues and New Perspectives	11
Management of Recurrent HPV-Positive Oropharyngeal Squamous Cell Carcinoma: a Contemporary Review	11
Targeted Therapy for Melanomas Without BRAF V600 Mutation	11
Postoperative Delirium and Neurocognitive Disorders: Updates for Providers Caring for Cancer Patients	11
Cardiac Arrhythmias in Oncological Patients—Epidemiology, Risk Factors, and Management within the Context of the New ESC 2022 Guidelines	11
Current Issues in Fertility Preservation Among Pediatric and Adolescent Cancer Patients	11
Recent Progress in Mind–Body Therapies in Cancer Care	11
Update on Percutaneous Ablation for Sarcoma	11
Novel Therapies for High-Risk Non-Muscle Invasive Bladder Cancer	11
Ablation of Kidney Tumors in Patients with Substantial Kidney Impairment: Current Status	10
Sequencing Targeted and Immune Therapy in BRAF-Mutant Melanoma: Lessons Learned	10
Current Trends and Challenges of Microbiome Research in Bladder Cancer	10
Managing Metastatic Extrapulmonary Neuroendocrine Carcinoma After First-Line Treatment	10
Immune-Related Adverse Events in Patients with Lung Cancer	10
Translocations and Gene Fusions in Sinonasal Malignancies	10
Non-squamous Cancers of the Larynx	10
De-escalation for Human Papillomavirus-Positive Oropharyngeal Cancer: A Look at the Prospective Evidence	10
Existing Health Inequities in the Treatment of Advanced and Metastatic Cancers	10
Antibody Drug Conjugates in Urological Cancers: A Review of the Current Landscape	10
Chemotherapy-Induced Peripheral Neuropathy: Diagnosis, Agents, General Clinical Presentation, and Treatments	10
Molecular Testing in Gliomas: What is Necessary in Routine Clinical Practice?	9
Systemic Therapy for Non-Melanoma Skin Cancers: Latest Advances	9

Approach to the Older Patient with Acute Myeloid Leukemia	9
Cardiovascular Toxicity and Risk Mitigation with Lung Cancer Treatment	9
Immune Checkpoint Inhibitors in Geriatric Oncology	9
Emerging Therapeutic Targets of Neuroendocrine Prostate Cancer	9
Aromatase Inhibitor Musculoskeletal Syndrome and Bone Loss: a Review of the Current Literature	9
Telehealth Utilization in Neuro-Oncology: Commentary on a Single Institution Experience After the COVID-19 Pandemic	9
Advances in Radiation Oncology in Soft Tissue Sarcoma	9
Cardiotoxicities of Non-Chemotherapeutic Metastatic Breast Cancer Treatments	9
Male Breast Cancer: a Review on Diagnosis, Treatment, and Survivorship	9
Surgery in the Era of Immunotherapy for Advanced Head and Neck Non-melanoma Skin Cancer	9
Oncolytic Viruses and Cancer Immunotherapy	9
Novel Clinical PET Tracers in the Pipeline for Melanoma	9
Addressing Residual Disease in HER2-Positive and Triple-Negative Breast Cancer: What Is Next?	8
Management of Central and Peripheral Nervous System Tumors in Patients with Neurofibromatosis	8
Perioperative Anticoagulation in Patients with Cancer	8
Current Status of Immunotherapy in Management of Small Bowel Neuroendocrine Tumors	8
Where Are We Now with Liver Transplantation in Neuroendocrine Neoplasms? The Place of Liver Transplantation for Grades 1 and 2 Well-Differentiated Unresectable Liver Metastatic Neuroendocrine Tumours	8
Interventional Treatment Options for Post-mastectomy Pain	8
Mucosal Melanoma: Epidemiology, Clinical Features, and Treatment	8
Antiangiogenic Therapy for Malignant Brain Tumors: Does It Still Matter?	8
Metronomic Chemotherapy in Elderly Patients	8
PEGylated IL-10: Clinical Development in Cancer Immunotherapy, Where to Go?	8
Stage 3 N2 Lung Cancer: A Multidisciplinary Therapeutic Conundrum	8
Art Therapy in Advanced Cancer. A Mapping Review of the Evidence	8
Integrating Functional Imaging and Molecular Profiling for Optimal Treatment Selection in Neuroendocrine Neoplasms (NEN)	8
Cellular Therapy for Children with Central Nervous System Tumors: Mining and Mapping the Correlative Data	8
From Detection to Cure – Emerging Roles for Urinary Tumor DNA (utDNA) in Bladder Cancer	8
Diagnostic and Therapeutic Updates in Leptomeningeal Disease	8
Developing a National Study That Integrates the Geriatric Assessment into the Care of Older Patients with Myeloid Malignancies	8
Resistance to KRAS G12C Inhibition in Non-small Cell Lung Cancer	8
Novel Clinical Trials and Approaches in the Management of Glioblastoma	8
Advances in Nasopharyngeal Carcinoma Staging: from the 7th to the 9th Edition of the TNM System and Future Outlook	8